John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Nike
NKE
|
+$175M |
| 2 |
Kroger
KR
|
+$148M |
| 3 |
Elevance Health
ELV
|
+$122M |
| 4 |
EA
Electronic Arts
EA
|
+$120M |
| 5 |
Abbott
ABT
|
+$119M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
|
+$181M |
| 2 |
Halliburton
HAL
|
+$152M |
| 3 |
Pfizer
PFE
|
+$145M |
| 4 |
AGN
Allergan plc
AGN
|
+$124M |
| 5 |
AutoZone
AZO
|
+$113M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.33% |
| 2 | Technology | 13.07% |
| 3 | Consumer Discretionary | 10.5% |
| 4 | Financials | 9.32% |
| 5 | Industrials | 9.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1676
CALL
The Mosaic Company
MOS
$7.68B
| $1.08M | ﹤0.01% |
+41,300
| New | +$1.1M |
|
1677
PUT
Parker-Hannifin
PH
$131B
| $1.08M | ﹤0.01% |
10,000
-13,000
| -57% | -$1.46M |
|
1678
Casella Waste Systems
CWST
$5.97B
| $1.08M | ﹤0.01% |
137,628
+12,091
| +10% | +$86.7K |
|
1679
Columbus McKinnon
CMCO
$519M
| $1.07M | ﹤0.01% |
75,887
-13,778
| -15% | -$213K |
|
1680
Methanex
MEOH
$4.4B
| $1.07M | ﹤0.01% |
+36,835
| New | +$1.18M |
|
|
MRO
1681
CALL
DELISTED
Marathon Oil Corporation
MRO
| $1.07M | ﹤0.01% |
71,000
-24,000
| -25% | -$317K |
|
|
HF
1682
DELISTED
HFF Inc.
HF
| $1.07M | ﹤0.01% |
36,895
-174,412
| -83% | -$5.24M |
|
1683
Immersion
IMMR
$255M
| $1.06M | ﹤0.01% |
144,903
+23,237
| +19% | +$164K |
|
1684
Accuray
ARAY
$31.6M
| $1.06M | ﹤0.01% |
204,498
+119,810
| +141% | +$655K |
|
1685
Coeur Mining
CDE
$22B
| $1.06M | ﹤0.01% |
99,450
-68,432
| -41% | -$538K |
|
1686
Spok Holdings
SPOK
$218M
| $1.06M | ﹤0.01% |
55,292
+19,467
| +54% | +$340K |
|
1687
State Street SPDR S&P Regional Banking ETF
KRE
$4.05B
| $1.06M | ﹤0.01% |
+27,620
| New | +$1.09M |
|
|
CUDA
1688
DELISTED
Barracuda Networks, Inc.
CUDA
| $1.06M | ﹤0.01% |
+69,904
| New | +$1.12M |
|
|
ALEX
1689
DELISTED
Alexander & Baldwin
ALEX
| $1.06M | ﹤0.01% |
29,245
+16,161
| +124% | +$596K |
|
1690
FTI Consulting
FCN
$4.19B
| $1.06M | ﹤0.01% |
25,961
+12,710
| +96% | +$503K |
|
|
VTLE
1691
PUT
DELISTED
Vital Energy
VTLE
| $1.05M | ﹤0.01% |
+5,035
| New | +$1.11M |
|
1692
Alibaba
BABA
$287B
| $1.05M | ﹤0.01% |
+13,234
| New | +$1.04M |
|
1693
Corcept Therapeutics
CORT
$13B
| $1.05M | ﹤0.01% |
192,732
+49,474
| +35% | +$257K |
|
1694
TriNet
TNET
$3.23B
| $1.05M | ﹤0.01% |
50,600
-91,034
| -64% | -$1.67M |
|
1695
Shinhan Financial Group
SHG
$36.4B
| $1.05M | ﹤0.01% |
32,105
+14,653
| +84% | +$503K |
|
1696
PUT
Regeneron Pharmaceuticals
REGN
$83.9B
| $1.05M | ﹤0.01% |
+3,000
| New | +$1.16M |
|
|
CARB
1697
DELISTED
Carbonite Inc
CARB
| $1.05M | ﹤0.01% |
107,570
+65,094
| +153% | +$571K |
|
|
DERM
1698
DELISTED
Dermira, Inc.
DERM
| $1.05M | ﹤0.01% |
+35,771
| New | +$987K |
|
1699
PUT
Las Vegas Sands
LVS
$29.9B
| $1.04M | ﹤0.01% |
24,000
-2,000
| -8% | -$93.4K |
|
|
SRDX
1700
DELISTED
Surmodics
SRDX
| $1.04M | ﹤0.01% |
44,428
+3,305
| +8% | +$72.4K |
|
Similar funds
John Overdeck's Q2 2016 Portfolio in Review
As of Q2 2016, John Overdeck held 3,523 positions worth $23.3B, up 11% from $21B the previous quarter. Its ten largest holdings account for 7.4% of the portfolio.
John Overdeck deployed $2B of net new capital in Q2 2016, opening 779 new positions and adding to 1,113 existing holdings. Its largest new stake was Kroger: 4,100,027 shares worth $151M.
By sector, the portfolio is most concentrated in Healthcare at 13% of assets, down from 13% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Pfizer, an estimated $145M trimmed.
- John Overdeck's largest Q2 2016 buy was Kroger: 4,100,027 shares worth $151M.
- John Overdeck added most to Nike in Q2 2016, an estimated $175M increase.
- John Overdeck's biggest Q2 2016 reduction was Pfizer, cutting an estimated $145M.
- John Overdeck fully exited TIME WARNER CABLE INC NEW COM STK in Q2 2016, selling an estimated $181M.
- John Overdeck's ten largest holdings make up 7.4% of its $23.3B portfolio in Q2 2016.
- John Overdeck opened 779 new positions and closed 661 in Q2 2016.
- John Overdeck's portfolio value rose 11% quarter-over-quarter to $23.3B.
Based on Two Sigma Investments's 13F filing for Q2 2016, filed 15 Aug 2016.